Gene variants in sortilin-1 (SORT1) [91] and interleukin-6 receptor (IL-6R) [92] have also been identified as risk variants for AAA, pointing to possible impairment of macrophage function with respect to LDL handling [93] and ‘alternative’ phenotype switching [94]. The gene discussed is IL6R; the disease is triple-A syndrome.